Pfizer Inc. (NYSE:PFE) shares are trading higher on Tuesday, as the stock benefits from a price forecast increase at Cantor Fitzgerald. The firm raised its forecast to $27 from $24, providing a catalyst for the pharmaceutical giant even as the broader healthcare sector declined 1.6% during the session.The move stands out against mixed market performance, with the S&P 500 gaining 0.42% and the Nasdaq climbing 0.89%, while the Dow Jones Industrial Average fell 1.01%.Recent Developments Supporting PfizerPfizer ...